NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Virus Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Virus Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Nasopharyngeal Carcinoma Therapy



Study data from Princess Margaret Hospital, Department of Radiation Oncology update understanding of nasopharyngeal carcinoma therapy



April 10th, 2007

Data detailed in "East-West Symposium on nasopharyngeal cancer" have been presented. In this recent study, researchers in Toronto, Canada conducted a study "To achieve greater understanding of the epidemiology, pathogenesis, molecular oncology, diagnostic, and therapeutic aspects of nasopharyngeal cancer (NPC), an international meeting was held in June 2005, Toronto, Canada. Further insights were obtained into the role of EBV in NPC development, with its diverse effects ranging from proliferative signals via NF-kB, to immunesuppression, to angiogenic gene regulation."

"Subsequently, multiple pathways are dysregulated in NPC as revealed by expression array analyses,...


Source: Virus Weekly (2007-04-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login